Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 8393-8400

  Li, Liang ^a   Li, Bin ^a   Zhang, Hao ^a   Bai, Shuwei ^a   Wang, Yichen ^a   Zhao, Bowen ^a   Jonas, Jost B ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE 1; CYCLINE; LENTIVIRUS VECTOR; PROTEIN P21; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR PAX6; CDC2 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN B; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EYE PROTEIN; HOMEODOMAIN PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; REPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; COLORIMETRY; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; WESTERN BLOTTING; CELL COUNT; CELL PROLIFERATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; LENTIVIRINAE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETINA TUMOR; TUMOR CELL CULTURE;

APOPTOSIS; BLOTTING, WESTERN; CELL COUNT; CELL PROLIFERATION; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EYE PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; IN SITU NICK-END LABELING; LENTIVIRUS; MICROSCOPY, FLUORESCENCE; PAIRED BOX TRANSCRIPTION FACTORS; PROLIFERATING CELL NUCLEAR ANTIGEN; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RETINAL NEOPLASMS; RETINOBLASTOMA; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855372392     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8139     Document Type: Article

References (38)

1. Dunn JM, Phillips RA, Becker AJ, Gallie BL. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science. 1988;241(4874):1797-1800.
2. Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer. 2007;46(7):617-634.
3. Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer. 2005;5(2):91-101.
4. Zhang J, Schweers B, Dyer MA. The first knockout mouse model of retinoblastoma. Cell Cycle. 2004;3(7):952-959.
5. Zhong X, Li Y, Peng F, et al. Identification of tumorigenic retinal stem-like cells in human solid retinoblastomas. Int J Cancer. 2007; 121(10):2125-2131.
6. Wang Q, Fang WH, Krupinski J, Kumar S, Slevin M, Kumar P. Pax genes in embryogenesis and oncogenesis. J Cell Mol Med. 2008; 12(6A):2281-2294.
7. Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA. PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol. 2007;73(1):1-14.
8. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene. 2003;22(39):7989-7997.
9. Lakowski J, Majumder A, Lauderdale JD. Mechanisms controlling Pax6 isoform expression in the retina have been conserved between teleosts and mammals. Dev Biol. 2007;307(2):498-520.
10. Larsen KB, Lutterodt M, Rath MF, Møller M. Expression of the homeobox genes PAX6, OTX2, and OTX1 in the early human fetal retina. Int J Dev Neurosci. 2009;27(5):485-492.
11. Kallur T, Gisler R, Lindvall O, Kokaia Z. Pax6 promotes neurogenesis in human neural stem cells. Mol Cell Neurosci. 2008;38(4): 616-628.
12. Sansom SN, Griffiths DS, Faedo A, et al. The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis. PLoS Genet. 2009; 5(6):e1000511.
13. Bai SW, Li B, Zhang H, et al. Pax6 regulates proliferation and apoptosis of human retinoblastoma cells. Invest Ophthalmol Vis Sci. 2011;52(7):4560-4570.
14. Hanawa H, Kelly PF, Nathwani AC, et al. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther. 2002;5(3):242-251.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods. 2001;25(4):402-408.
16. Mascarenhas JB, Young KP, Littlejohn EL, Yoo BK, Salgia R, Lang D. PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene. J Biol Chem. 2009;284(40):27524-27532.
17. Lang D, Mascarenhas JB, Powell SK, Halegoua J, Nelson M, Ruggeri BA. PAX6 is expressed in pancreatic adenocarcinoma and is downregulated during induction of terminal differentiation. Mol Carcinog. 2008;47(2):148-156.
18. Zhou YH, Wu X, Tan F, et al. PAX6 suppresses growth of human glioblastoma cells. J Neurooncol. 2005;71(3):223-229.
19. Mayes DA, Hu Y, Teng Y, et al. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Res. 2006;66(20):9809-9817.
20. Shyr CR, Tsai MY, Yeh S, et al. Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth. Prostate. 2010;70(2):190-199.
21. Huang S, Ingber DE. The structural and mechanical complexity of cell-growth control. Nat Cell Biol. 1999;1(5):E131-E138.
22. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100(1):57-70.
23. Xu S, Sunderland ME, Coles BL, et al. The proliferation and expansion of retinal stem cells require functional Pax6. Dev Biol. 2007; 304(2):713-721.
24. Hsieh YW, Yang XJ. Dynamic Pax6 expression during the neurogenic cell cycle influences proliferation and cell fate choices of retinal progenitors. Neural Dev. 2009;4:32.
25. Zhou YH, Hu Y, Mayes D, et al. PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A. J Neurooncol. 2010;96(2):191-200.
26. He G, Siddik ZH, Huang Z, et al. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene. 2005;24(18):2929-2943.
27. Cayrol C, Knibiehler M, Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene. 1998;16(3):311-320.
28. Frouin I, Maga G, Denegri M, et al. Human proliferating cell nuclear antigen, poly (ADP-ribose) polymerase-1, and p21waf1/ cip1: a dynamic exchange of partners. J Biol Chem. 2003;278(41): 39265-39268.
29. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998; 282(5393):1497-1501.
30. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene. 2001;20(15):1803-1815.
31. Møller MB. P27 in cell cycle control and cancer. Leuk Lymphoma. 2000;39(1-2):19-27.
32. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 2003;13(2): 65-70.
33. Kase S, Yoshida K, Ohgami K, Shiratori K, Harada T, Ohno S. Expression of p27(KIP1) and cell proliferation in human retina and retinoblastoma. Anticancer Res. 2005;25(6B):3843-3846.
34. Kase S, Yoshida K, Ohgami K, et al. Expression of cdc2 and p27(KIP1) phosphorylation in mitotic cells of the human retinoblastoma. Int J Mol Med. 2006;17(3):465-468.
35. Meulmeester E, Jochemsen AG. p53: a guide to apoptosis. Curr Cancer Drug Targets. 2008;8(2):87-97.
36. Salvesen GS, Riedl SJ. Caspase mechanisms. Adv Exp Med Biol. 2008;615:13-23.
37. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008;9(3):231-241.
38. Ouyang J, Shen YC, Yeh LK, et al. Pax6 overexpression suppresses cell proliferation and retards the cell cycle in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2006;47(6):2397-2407.